Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
Chapter 5: CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
Chapter 6: CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
Chapter 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
Chapter 8: COMPANY PROFILES
8.1. Roche
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Abbott
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Siemens Healthcare
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Johnson & Johnson
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Medtronic
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. A. Menarini Diagnostics
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Biosense Medical
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Sannuo Medical Technologies
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Optimum Diagnostics
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Sysmex Biomedical
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN CHINA POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: CHINA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: CHINA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ROCHE: NET SALES, 2020-2022*?($MILLION)
FIGURE 21. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ABBOTT: NET SALES, 2020-2022*?($MILLION)
FIGURE 24. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. SIEMENS HEALTHCARE: NET SALES, 2020-2022*?($MILLION)
FIGURE 27. SIEMENS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. SIEMENS HEALTHCARE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. JOHNSON & JOHNSON: NET SALES, 2020-2022*?($MILLION)
FIGURE 30. JOHNSON & JOHNSON: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. JOHNSON & JOHNSON: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. MEDTRONIC: NET SALES, 2020-2022*?($MILLION)
FIGURE 33. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. A. MENARINI DIAGNOSTICS: NET SALES, 2020-2022*?($MILLION)
FIGURE 36. A. MENARINI DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. A. MENARINI DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. BIOSENSE MEDICAL: NET SALES, 2020-2022*?($MILLION)
FIGURE 39. BIOSENSE MEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. BIOSENSE MEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. SANNUO MEDICAL TECHNOLOGIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 42. SANNUO MEDICAL TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. SANNUO MEDICAL TECHNOLOGIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. OPTIMUM DIAGNOSTICS: NET SALES, 2020-2022*?($MILLION)
FIGURE 45. OPTIMUM DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. OPTIMUM DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. SYSMEX BIOMEDICAL: NET SALES, 2020-2022*?($MILLION)
FIGURE 48. SYSMEX BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. SYSMEX BIOMEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ROCHE: KEY EXECUTIVES
TABLE 05. ROCHE: COMPANY SNAPSHOT
TABLE 06. ROCHE: OPERATING SEGMENTS
TABLE 07. ROCHE: PRODUCT PORTFOLIO
TABLE 08. ROCHE: KEY STRATERGIES
TABLE 09. ABBOTT: KEY EXECUTIVES
TABLE 10. ABBOTT: COMPANY SNAPSHOT
TABLE 11. ABBOTT: OPERATING SEGMENTS
TABLE 12. ABBOTT: PRODUCT PORTFOLIO
TABLE 13. ABBOTT: KEY STRATERGIES
TABLE 14. SIEMENS HEALTHCARE: KEY EXECUTIVES
TABLE 15. SIEMENS HEALTHCARE: COMPANY SNAPSHOT
TABLE 16. SIEMENS HEALTHCARE: OPERATING SEGMENTS
TABLE 17. SIEMENS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 18. SIEMENS HEALTHCARE: KEY STRATERGIES
TABLE 19. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 20. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 21. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 22. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 23. JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 24. MEDTRONIC: KEY EXECUTIVES
TABLE 25. MEDTRONIC: COMPANY SNAPSHOT
TABLE 26. MEDTRONIC: OPERATING SEGMENTS
TABLE 27. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 28. MEDTRONIC: KEY STRATERGIES
TABLE 29. A. MENARINI DIAGNOSTICS: KEY EXECUTIVES
TABLE 30. A. MENARINI DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 31. A. MENARINI DIAGNOSTICS: OPERATING SEGMENTS
TABLE 32. A. MENARINI DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 33. A. MENARINI DIAGNOSTICS: KEY STRATERGIES
TABLE 34. BIOSENSE MEDICAL: KEY EXECUTIVES
TABLE 35. BIOSENSE MEDICAL: COMPANY SNAPSHOT
TABLE 36. BIOSENSE MEDICAL: OPERATING SEGMENTS
TABLE 37. BIOSENSE MEDICAL: PRODUCT PORTFOLIO
TABLE 38. BIOSENSE MEDICAL: KEY STRATERGIES
TABLE 39. SANNUO MEDICAL TECHNOLOGIES: KEY EXECUTIVES
TABLE 40. SANNUO MEDICAL TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 41. SANNUO MEDICAL TECHNOLOGIES: OPERATING SEGMENTS
TABLE 42. SANNUO MEDICAL TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 43. SANNUO MEDICAL TECHNOLOGIES: KEY STRATERGIES
TABLE 44. OPTIMUM DIAGNOSTICS: KEY EXECUTIVES
TABLE 45. OPTIMUM DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 46. OPTIMUM DIAGNOSTICS: OPERATING SEGMENTS
TABLE 47. OPTIMUM DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 48. OPTIMUM DIAGNOSTICS: KEY STRATERGIES
TABLE 49. SYSMEX BIOMEDICAL: KEY EXECUTIVES
TABLE 50. SYSMEX BIOMEDICAL: COMPANY SNAPSHOT
TABLE 51. SYSMEX BIOMEDICAL: OPERATING SEGMENTS
TABLE 52. SYSMEX BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 53. SYSMEX BIOMEDICAL: KEY STRATERGIES